These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 34535527)

  • 1. Monitoring New Symptoms After COVID-19 Infection Among Primary Care Patients in New York City.
    Terlizzi K; Kutscher E; Yoncheva Y
    J Am Board Fam Med; 2021; 34(5):1014-1016. PubMed ID: 34535527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
    Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
    BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The other COVID-19 survivors: Timing, duration, and health impact of post-acute sequelae of SARS-CoV-2 infection.
    Lambert N; ; El-Azab SA; Ramrakhiani NS; Barisano A; Yu L; Taylor K; Esperança Á; Mendiola C; Downs CA; Abrahim HL; Hughes T; Rahmani AM; Borelli JL; Chakraborty R; Pinto MD
    J Clin Nurs; 2024 Jan; 33(1):76-88. PubMed ID: 36181315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long COVID outcomes following omicron wave in non-hospital population.
    Ruiyin W; Qi J; Tingting W; Yuqin Y; Yan J; Kun P
    Front Public Health; 2024; 12():1377866. PubMed ID: 38560433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of ICD-10 Code U09.9 Documentation and Clinical Characteristics of VA Patients With Post-COVID-19 Condition.
    Wander PL; Baraff A; Fox A; Cho K; Maripuri M; Honerlaw JP; Ho YL; Dey AT; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Viglianti E; Iwashyna TJ; Hynes DM; Osborne TF; Ioannou GN
    JAMA Netw Open; 2023 Dec; 6(12):e2346783. PubMed ID: 38064215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Before and after COVID-19: Changes in symptoms and diagnoses in 13,033 adults.
    Butler MJ; Chiuzan C; Ahn H; Gao M; D'Angelo S; Yeh J; Davidson K
    PLoS One; 2024; 19(3):e0286371. PubMed ID: 38457409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study.
    Stephenson T; Pinto Pereira SM; Nugawela MD; McOwat K; Simmons R; Chalder T; Ford T; Heyman I; Swann OV; Fox-Smith L; Rojas NK; Dalrymple E; Ladhani SN; Shafran R;
    PLoS One; 2023; 18(3):e0277704. PubMed ID: 36877677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults.
    Zhang Y; Romieu-Hernandez A; Boehmer TK; Azziz-Baumgartner E; Carton TW; Gundlapalli AV; Fearrington J; Nagavedu K; Dea K; Moyneur E; Cowell LG; Kaushal R; Mayer KH; Puro J; Rasmussen SA; Thacker D; Weiner MG; Saydah S; Block JP;
    BMC Infect Dis; 2024 Feb; 24(1):181. PubMed ID: 38341566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System.
    Ioannou GN; Baraff A; Fox A; Shahoumian T; Hickok A; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Bowling CB; Viglianti E; Iwashyna TJ; Hynes DM
    JAMA Netw Open; 2022 Jul; 5(7):e2224359. PubMed ID: 35904783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent CD8
    LaVergne SM; Dutt TS; McFann K; Baxter BA; Webb TL; Berry K; Tipton M; Stromberg S; Sullivan BM; Dunn J; Henao-Tamayo M; Ryan EP
    Front Immunol; 2023; 14():1303971. PubMed ID: 38327763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up.
    Heidemann C; Sarganas G; Du Y; Gaertner B; Poethko-Müller C; Cohrdes C; Schmidt S; Schlaud M; Scheidt-Nave C
    BMC Public Health; 2023 Aug; 23(1):1587. PubMed ID: 37605232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors.
    Brunner-Ziegler S; Bäuerle M; Brühl P; Kornek G; Parschalk B; Savic R; Schnetzinger M; Spath T; Straßl RP; Handisurya A; Thalhammer F
    J Infect Public Health; 2023 Apr; 16(4):596-602. PubMed ID: 36842195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series.
    Shoucri SM; Purpura L; DeLaurentis C; Adan MA; Theodore DA; Irace AL; Robbins-Juarez SY; Khedagi AM; Letchford D; Harb AA; Zerihun LM; Lee KE; Gambina K; Lauring MC; Chen N; Sperring CP; Mehta SS; Myers EL; Shih H; Argenziano MG; Bruce SL; Slater CL; Tiao JR; Natarajan K; Hripcsak G; Chen R; Yin MT; Sobieszczyk ME; Castor D; Zucker JE
    BMJ Open; 2021 Jun; 11(6):e049488. PubMed ID: 34083350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring the development of post-COVID–19 syndrome].
    Tamasi J; Kalabay L
    Orv Hetil; 2022 Feb; 163(9):335-342. PubMed ID: 35220274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
    Dagher H; Chaftari AM; Subbiah IM; Malek AE; Jiang Y; Lamie P; Granwehr B; John T; Yepez E; Borjan J; Reyes-Gibby C; Flores M; Khawaja F; Pande M; Ali N; Rojo R; Karp DD; Chaftari P; Hachem R; Raad II
    Elife; 2023 Feb; 12():. PubMed ID: 36748905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving phenotypes of non-hospitalized patients that indicate long COVID.
    Estiri H; Strasser ZH; Brat GA; Semenov YR; ; Patel CJ; Murphy SN
    BMC Med; 2021 Sep; 19(1):249. PubMed ID: 34565368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.